Ricardo Pasquini

Validation of the EBMT risk score in chronic myeloid leukemia in Brazil and allogeneic transplant outcome.

Daniel Tabak, Afonso Celso Vigorito, Carmino Antonio De Souza, 2005, Haematologica.

Tanchella: Una Herramienta para la Recolección de Datos de la Web

Gabriela Robiolo, Ricardo Pasquini, Javier Isoldi, 2017, Conferencia Iberoamericana de Software Engineering.

Estudo retrospectivo do tratamento de leucemia mielóide aguda com o transplante de medula óssea: a experiência brasileira

Afonso Celso Vigorito, Belinda Pinto Simões, Lilian Piron-Ruiz, 2006 .

Quality of life of chronic myeloid leukemia patients in Brazil: ability to work as a key factor

Daniel Tabak, Ricardo Pasquini, Nelson Hamerschlak, 2014, Supportive Care in Cancer.

Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia.

Manuel Ayala, Ricardo Pasquini, Jorge Cortes, 2010, The New England journal of medicine.

The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts.

Francisco Cervantes, Ryuzo Ohno, Richard E. Clark, 2013, Blood.

Phase III, randomized, open-label study of daily imatinib mesylate 400 mg versus 800 mg in patients with newly diagnosed, previously untreated chronic myeloid leukemia in chronic phase using molecular end points: tyrosine kinase inhibitor optimization and selectivity study.

Susan Branford, Ricardo Pasquini, Fabrizio Pane, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

TLR8-dependent TNF-(alpha) overexpression in Fanconi anemia group C cells.

Jane Yates, Ricardo Pasquini, C. Harrington, 2009, Blood.

Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia.

Ricardo Pasquini, Giuseppe Saglio, Andreas Hochhaus, 2010, The New England journal of medicine.

Are the review criteria for automated complete blood counts of the International Society of Laboratory Hematology suitable for all hematology laboratories?

Ricardo Pasquini, R. Pasquini, Samuel Ricardo Comar, 2014, Revista brasileira de hematologia e hemoterapia.